nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—CYP1A2—Imiquimod—skin cancer	0.136	0.147	CbGbCtD
Clevidipine—CYP2C19—Vismodegib—skin cancer	0.102	0.111	CbGbCtD
Clevidipine—CYP2E1—Dacarbazine—skin cancer	0.0986	0.107	CbGbCtD
Clevidipine—CYP2C9—Vismodegib—skin cancer	0.0848	0.092	CbGbCtD
Clevidipine—CYP1A2—Vemurafenib—skin cancer	0.0744	0.0807	CbGbCtD
Clevidipine—CYP3A4—Temozolomide—skin cancer	0.0712	0.0772	CbGbCtD
Clevidipine—CYP3A4—Imiquimod—skin cancer	0.0712	0.0772	CbGbCtD
Clevidipine—CYP2D6—Vemurafenib—skin cancer	0.0613	0.0665	CbGbCtD
Clevidipine—CYP1A2—Dacarbazine—skin cancer	0.057	0.0619	CbGbCtD
Clevidipine—CYP3A4—Vismodegib—skin cancer	0.0493	0.0535	CbGbCtD
Clevidipine—CYP3A4—Vemurafenib—skin cancer	0.039	0.0423	CbGbCtD
Clevidipine—CACNA1S—pes—skin cancer	0.0347	0.543	CbGeAlD
Clevidipine—CYP1A2—Fluorouracil—skin cancer	0.0334	0.0363	CbGbCtD
Clevidipine—CYP2C9—Fluorouracil—skin cancer	0.0301	0.0327	CbGbCtD
Clevidipine—CYP3A4—Docetaxel—skin cancer	0.0134	0.0145	CbGbCtD
Clevidipine—CACNA1D—ear—skin cancer	0.00802	0.125	CbGeAlD
Clevidipine—CACNA1F—head—skin cancer	0.00405	0.0632	CbGeAlD
Clevidipine—CACNA1C—connective tissue—skin cancer	0.00188	0.0293	CbGeAlD
Clevidipine—BCHE—nipple—skin cancer	0.00145	0.0227	CbGeAlD
Clevidipine—CYP1A2—nipple—skin cancer	0.00135	0.0211	CbGeAlD
Clevidipine—CACNA1C—female reproductive system—skin cancer	0.00132	0.0207	CbGeAlD
Clevidipine—CACNA1D—head—skin cancer	0.0012	0.0187	CbGeAlD
Clevidipine—CACNA1C—head—skin cancer	0.00111	0.0173	CbGeAlD
Clevidipine—Atrial fibrillation—Vemurafenib—skin cancer	0.000959	0.0672	CcSEcCtD
Clevidipine—BCHE—skin of body—skin cancer	0.000929	0.0145	CbGeAlD
Clevidipine—BCHE—mammalian vulva—skin cancer	0.000848	0.0132	CbGeAlD
Clevidipine—CACNA1D—lymph node—skin cancer	0.000839	0.0131	CbGeAlD
Clevidipine—Atrial fibrillation—Imiquimod—skin cancer	0.000818	0.0573	CcSEcCtD
Clevidipine—CACNA1C—lymph node—skin cancer	0.000774	0.0121	CbGeAlD
Clevidipine—BCHE—female reproductive system—skin cancer	0.000726	0.0113	CbGeAlD
Clevidipine—CYP2C9—female reproductive system—skin cancer	0.000641	0.01	CbGeAlD
Clevidipine—CYP2E1—lymphoid tissue—skin cancer	0.00063	0.00984	CbGeAlD
Clevidipine—CYP2E1—female reproductive system—skin cancer	0.000607	0.00949	CbGeAlD
Clevidipine—BCHE—head—skin cancer	0.000606	0.00947	CbGeAlD
Clevidipine—Ileus—Docetaxel—skin cancer	0.000601	0.0421	CcSEcCtD
Clevidipine—Acute coronary syndrome—Imiquimod—skin cancer	0.000589	0.0413	CcSEcCtD
Clevidipine—Myocardial infarction—Imiquimod—skin cancer	0.000586	0.041	CcSEcCtD
Clevidipine—CYP2E1—head—skin cancer	0.000507	0.00793	CbGeAlD
Clevidipine—CYP3A4—female reproductive system—skin cancer	0.000489	0.00763	CbGeAlD
Clevidipine—CYP2D6—female reproductive system—skin cancer	0.000481	0.00751	CbGeAlD
Clevidipine—Vomiting—Vismodegib—skin cancer	0.00046	0.0322	CcSEcCtD
Clevidipine—Nausea—Vismodegib—skin cancer	0.00043	0.0301	CcSEcCtD
Clevidipine—BCHE—lymph node—skin cancer	0.000425	0.00663	CbGeAlD
Clevidipine—Acute coronary syndrome—Bleomycin—skin cancer	0.000418	0.0293	CcSEcCtD
Clevidipine—Hypotension—Vemurafenib—skin cancer	0.000417	0.0293	CcSEcCtD
Clevidipine—Myocardial infarction—Bleomycin—skin cancer	0.000416	0.0292	CcSEcCtD
Clevidipine—CYP2D6—head—skin cancer	0.000402	0.00628	CbGeAlD
Clevidipine—Tachycardia—Imiquimod—skin cancer	0.000372	0.0261	CcSEcCtD
Clevidipine—Dyspnoea—Imiquimod—skin cancer	0.00034	0.0238	CcSEcCtD
Clevidipine—Hypersensitivity—Vemurafenib—skin cancer	0.000329	0.0231	CcSEcCtD
Clevidipine—Atrial fibrillation—Docetaxel—skin cancer	0.000326	0.0228	CcSEcCtD
Clevidipine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000325	0.0228	CcSEcCtD
Clevidipine—Myocardial infarction—Fluorouracil—skin cancer	0.000323	0.0227	CcSEcCtD
Clevidipine—Vomiting—Vemurafenib—skin cancer	0.000284	0.0199	CcSEcCtD
Clevidipine—Hypersensitivity—Imiquimod—skin cancer	0.000281	0.0197	CcSEcCtD
Clevidipine—Headache—Vemurafenib—skin cancer	0.00028	0.0196	CcSEcCtD
Clevidipine—Nausea—Vemurafenib—skin cancer	0.000265	0.0186	CcSEcCtD
Clevidipine—Hypotension—Bleomycin—skin cancer	0.000253	0.0177	CcSEcCtD
Clevidipine—Vomiting—Imiquimod—skin cancer	0.000242	0.017	CcSEcCtD
Clevidipine—Dyspnoea—Bleomycin—skin cancer	0.000241	0.0169	CcSEcCtD
Clevidipine—Headache—Imiquimod—skin cancer	0.000239	0.0167	CcSEcCtD
Clevidipine—Acute coronary syndrome—Docetaxel—skin cancer	0.000235	0.0164	CcSEcCtD
Clevidipine—Myocardial infarction—Docetaxel—skin cancer	0.000233	0.0164	CcSEcCtD
Clevidipine—Nausea—Imiquimod—skin cancer	0.000226	0.0159	CcSEcCtD
Clevidipine—Tachycardia—Fluorouracil—skin cancer	0.000205	0.0144	CcSEcCtD
Clevidipine—Dyspnoea—Temozolomide—skin cancer	0.000204	0.0143	CcSEcCtD
Clevidipine—Hypersensitivity—Bleomycin—skin cancer	0.000199	0.014	CcSEcCtD
Clevidipine—Hypotension—Fluorouracil—skin cancer	0.000197	0.0138	CcSEcCtD
Clevidipine—Dyspnoea—Fluorouracil—skin cancer	0.000188	0.0131	CcSEcCtD
Clevidipine—Hypersensitivity—Dactinomycin—skin cancer	0.000186	0.013	CcSEcCtD
Clevidipine—Vomiting—Bleomycin—skin cancer	0.000172	0.0121	CcSEcCtD
Clevidipine—Hypersensitivity—Temozolomide—skin cancer	0.000168	0.0118	CcSEcCtD
Clevidipine—Nausea—Bleomycin—skin cancer	0.000161	0.0113	CcSEcCtD
Clevidipine—Vomiting—Dactinomycin—skin cancer	0.000161	0.0112	CcSEcCtD
Clevidipine—Hypersensitivity—Fluorouracil—skin cancer	0.000155	0.0109	CcSEcCtD
Clevidipine—Nausea—Dactinomycin—skin cancer	0.00015	0.0105	CcSEcCtD
Clevidipine—Tachycardia—Docetaxel—skin cancer	0.000148	0.0104	CcSEcCtD
Clevidipine—Vomiting—Temozolomide—skin cancer	0.000145	0.0102	CcSEcCtD
Clevidipine—Headache—Temozolomide—skin cancer	0.000143	0.01	CcSEcCtD
Clevidipine—Hypotension—Docetaxel—skin cancer	0.000142	0.00994	CcSEcCtD
Clevidipine—Nausea—Temozolomide—skin cancer	0.000136	0.0095	CcSEcCtD
Clevidipine—Dyspnoea—Docetaxel—skin cancer	0.000135	0.00949	CcSEcCtD
Clevidipine—Vomiting—Fluorouracil—skin cancer	0.000134	0.00937	CcSEcCtD
Clevidipine—Headache—Fluorouracil—skin cancer	0.000132	0.00924	CcSEcCtD
Clevidipine—Nausea—Fluorouracil—skin cancer	0.000125	0.00876	CcSEcCtD
Clevidipine—Hypersensitivity—Docetaxel—skin cancer	0.000112	0.00784	CcSEcCtD
Clevidipine—Vomiting—Docetaxel—skin cancer	9.65e-05	0.00677	CcSEcCtD
Clevidipine—Headache—Docetaxel—skin cancer	9.51e-05	0.00667	CcSEcCtD
Clevidipine—Nausea—Docetaxel—skin cancer	9.02e-05	0.00632	CcSEcCtD
